ANAIS MALPICA to Neoadjuvant Therapy
This is a "connection" page, showing publications ANAIS MALPICA has written about Neoadjuvant Therapy.
Connection Strength
0.362
-
A 3-Tier Chemotherapy Response Score for Ovarian/Fallopian Tube/Peritoneal High-grade Serous Carcinoma: Is it Clinically Relevant? Am J Surg Pathol. 2020 02; 44(2):206-213.
Score: 0.268
-
TP53 variant allele frequency correlates with the chemotherapy response score in ovarian/fallopian tube/peritoneal high-grade serous carcinoma. Hum Pathol. 2021 09; 115:76-83.
Score: 0.074
-
Ovarian Low-grade Serous Carcinoma: A Clinicopathologic Study of 33 Cases With Primary Surgery Performed at a Single Institution. Am J Surg Pathol. 2016 May; 40(5):627-35.
Score: 0.013
-
Neoadjuvant chemotherapy for low-grade serous carcinoma of the ovary or peritoneum. Gynecol Oncol. 2008 Mar; 108(3):510-4.
Score: 0.007